<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DA0437CC-F637-41CB-8544-DFA50F04360C"><gtr:id>DA0437CC-F637-41CB-8544-DFA50F04360C</gtr:id><gtr:name>National Research Council CNR - Italy</gtr:name><gtr:address><gtr:line1>National Research Council CNR</gtr:line1><gtr:line2>P le Aldo Moro 7</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DA0437CC-F637-41CB-8544-DFA50F04360C"><gtr:id>DA0437CC-F637-41CB-8544-DFA50F04360C</gtr:id><gtr:name>National Research Council CNR - Italy</gtr:name><gtr:address><gtr:line1>National Research Council CNR</gtr:line1><gtr:line2>P le Aldo Moro 7</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6DF6EBA7-88E8-4A28-8887-9E77FCE1708C"><gtr:id>6DF6EBA7-88E8-4A28-8887-9E77FCE1708C</gtr:id><gtr:firstName>Catherine</gtr:firstName><gtr:surname>Lindon</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G120%2F892"><gtr:id>3803EBFF-E205-4CDE-9CBC-1113B35C68C8</gtr:id><gtr:title>What is the role of proteolysis in completing cell division?</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G120/892</gtr:grantReference><gtr:abstractText>Cell division is a process requiring the repackaging of duplicated chromosomes into two identical daughter cells. This involves a series of events that are tightly regulated in time and in space, and which must be correctly co-ordinated to avoid mistakes in the distribution of chromosomes. Such mistakes are thought to be an important step in the progression of cancers, which frequently have large numbers of extra chromosomes (genome instability), allowing tumours to acquire more aggressive characteristics. I propose to use video-microscopy of human cells growing under laboratory conditions, to study the mechanisms of the cell division process (called mitosis). In particular, I want to test the idea that some of the known regulators of mitosis, encoded by genes which have been linked to several tumour types, must be destroyed by the cell in order for it to successfully complete cell division. These studies will improve our understanding of the normal cell division process, by identifying when, where and why these regulators are destroyed. We will identify roles for these regulators in mechanisms giving rise to genome instability. Furthermore these regulators are considered to be potential targets for anti-cancer drugs, and our video-microscopy studies will allow us to test this idea.</gtr:abstractText><gtr:technicalSummary>We aim to identify mechanisms that bring about timed destruction of key regulators of cell division. Our studies will focus on Polo-like kinase (Plk1) and Aurora kinase, regulators whose mis-expression is associated with cancer.
Proteolysis mediated by the anaphase-promoting complex (APC/C) ubiquitin ligase is known to be a key mechanism controlling cell division, since inhibition of the APC/C by the spindle checkpoint prevents mitotic exit until all sister chromatids are correctly attached to the mitotic spindle. This checkpoint is essential for preserving genomic stability. During mitotic exit sister chromatids are segregated to opposite poles of the spindle in anaphase, after which the spindle disassembles and the cell cleaves by cytokinesis to produce two identical daughter cells. Although there are known substrates of APC/C-dependent proteolysis after the onset of anaphase (such as Plk1 and Aurora), it is not known how this proteolysis is regulated. Furthermore, although there is evidence, from our lab and from others, that the proper levels of Plk1 and AuroraA are essential for the execution of cytokinesis, the importance of their proteolysis has not been established. I propose to examine these questions using Plk1 and Aurora kinases as model substrates in an approach which combines fluorescent protein (FP) technology with video-microscopy of living cells: FP-tagged versions of Aurora kinase and Plk1 can be used as markers for these regulators in live cells and time-lapse imaging reveals both quantitative and qualitative information in 4-dimensions (for example, when and where these proteins are destroyed). I propose to identify the mechanisms regulating proteolysis of Aurora and Plk1 kinases, and to characterise, through studies of fixed and live cells with cytokinesis markers, the defects in mitotic exit which arise from interfering with their destruction, We expect to find that proteolysis during mitotic exit is required for the co-ordination of cytokinesis with sister chromatid separation and therefore essential for the fidelity of cell division. This work is directly relevant to the search for the causes of cancer and of tumour progression. 
Furthermore, I wish to test the possibility of developing a generally applicable fluorescence-based assay for substrate ubiquitination. This will be carried out in collaboration with the Chemical Engineering Department in Cambridge (Dr Clemens Kaminski), and if successful will provide an important opportunity for examining altered pattens of proteolysis implicatd in several virus-mediated cancer pathologies.</gtr:technicalSummary><gtr:fund><gtr:end>2009-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>460718</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Institute for Medical Research (CIMR)</gtr:department><gtr:description>A role for spastin in cytokinesis</gtr:description><gtr:id>5758E78A-D760-40D4-A234-F6F84785EA32</gtr:id><gtr:impact>19000169</gtr:impact><gtr:outcomeId>B0ECD94F9E2-1</gtr:outcomeId><gtr:piContribution>analysis of cytokinesis defect after knockdown of microtubule severing AAA-ATPase spastin</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory for Molecular Cell Biology</gtr:department><gtr:description>Testing K11-ubiquitin linkages on Aurora kinases</gtr:description><gtr:id>ED9D842F-BF4E-4247-9509-C4916AD01F46</gtr:id><gtr:impact>Publication Min et al. (2015). doi: 10.1091/mbc.E15-02-0102</gtr:impact><gtr:outcomeId>56d85f290aaed4.39683040-1</gtr:outcomeId><gtr:partnerContribution>DUBs restriction assays on ubiquitinated material conjugated on Aurora kinases from mitotic cells</gtr:partnerContribution><gtr:piContribution>Purifying ubiquitinated Aurora kinases from human cells for testing in DUBs restriction assay for ubiquitin linkage types</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Research Council</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Targeting Aurora A stability in cancers through its interaction with TPX2</gtr:description><gtr:id>C24D88F5-8216-423D-B71F-19A790B1BA95</gtr:id><gtr:impact>http://dx.doi.org/10.1016/j.bbcan.2010.08.001
http://dx.doi.org/10.1242/jcs.075457</gtr:impact><gtr:outcomeId>205B34D5C7F-1</gtr:outcomeId><gtr:partnerContribution>We have exchanged reagents &amp;amp; ideas &amp;amp; conducted experiments towards joint publications. An ex-student from Dr Guarguaglini's lab came to work as my research assistant when my postdoc left after working out her maternity leave.</gtr:partnerContribution><gtr:piContribution>We have exchanged reagents &amp;amp; ideas &amp;amp; conducted experiments towards joint publications, with Dr Giulia Guarguaglini and her lab. We are planning further publications together in the next 3 years.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Measuring ubiquitination by FRET</gtr:description><gtr:id>99DAFB5B-7864-4FC1-9E82-634AC64FE651</gtr:id><gtr:impact>Elder et al. (2009)</gtr:impact><gtr:outcomeId>jYZzhmfAShB-1</gtr:outcomeId><gtr:partnerContribution>capability for fluorescence lifetime imaging (FLIM) as a method to measure FRET</gtr:partnerContribution><gtr:piContribution>generating tools for cell-based FRET assays</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>215000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK funding (Proteolysis of Aurora kinases and the control of cytokinesis)</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>40A11CB9-AF1B-4528-8415-FDC3888E3227</gtr:id><gtr:outcomeId>A696CFAC4B90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>A stable human cell line (U2OS) expressing multiple copies of biotinylated ubiquitin under tight control by tetracycline. This cell line enables clean and easy identification and quantification of ubiquitin substrates, studies of ubiquitination mechanisms and ubiquitination inhibitor screens.</gtr:description><gtr:grantRef>G120/892</gtr:grantRef><gtr:id>D6E6F7A0-56C6-4061-B64B-5F7A625E7C2A</gtr:id><gtr:impact>Publications in 2013 and 2014</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>msHRo2u2RrE</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>bioUb cells</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>protocol devised to overcome problems of chronic RNAi-mediated depletion of cell cycle regulators (cells are typically assayed 48 hours after RNAi treatment, whereas the cell cycle in human cells is only 24 hours). This protocol allows us to study cells undergoing their first division after depletion of a cell cycle regulator.</gtr:description><gtr:id>FB7A4CFE-3EA6-4D7E-B56E-64514FCB8990</gtr:id><gtr:impact>characterization of mitotic division in the absence of Cdh1 regulator</gtr:impact><gtr:outcomeId>F582D9FF450</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>combined RNAi/synchronization protocol</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Human cell line expressing in vivo-biotinylated ubiquitin that can be used for efficient purification of polyubiquitinated material.</gtr:description><gtr:id>CF3D31A5-9DB5-4447-8143-47676373CA90</gtr:id><gtr:impact>research impacts, potential commercial impact</gtr:impact><gtr:outcomeId>mNAHX6AwYBG</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>bioUb cells</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>https://www.researchgate.net/publication/262608232_Using_in_vivo-biotinylated_ubiquitin_to_describe_a_mitotic_exit_ubiquitome_from_human_cells</gtr:url><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BD0CC2D5-710A-4476-84CE-9E75324F9640</gtr:id><gtr:title>Using in vivo biotinylated ubiquitin to describe a mitotic exit ubiquitome from human cells.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/816ef8b1b2073b67a9afcf678ca5a97f"><gtr:id>816ef8b1b2073b67a9afcf678ca5a97f</gtr:id><gtr:otherNames>Min M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn><gtr:outcomeId>58ac1c56bfb549.25041343</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10D17059-60DE-44A2-AECD-22DF5FE9AFBD</gtr:id><gtr:title>APC/C Cdh1 targets aurora kinase to control reorganization of the mitotic spindle at anaphase.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dff684aa563c661949242d8c548044ce"><gtr:id>dff684aa563c661949242d8c548044ce</gtr:id><gtr:otherNames>Floyd S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>A72D675587A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2705C9E6-B97D-45E9-8EEB-FD3B4652676B</gtr:id><gtr:title>Ubiquitination site preferences in anaphase promoting complex/cyclosome (APC/C) substrates.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/816ef8b1b2073b67a9afcf678ca5a97f"><gtr:id>816ef8b1b2073b67a9afcf678ca5a97f</gtr:id><gtr:otherNames>Min M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>58ac1c574631b6.88555347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E1AA4C8-B654-4108-AC91-820E54C2C4DA</gtr:id><gtr:title>A quantitative protocol for dynamic measurements of protein interactions by Forster resonance energy transfer-sensitized fluorescence emission</gtr:title><gtr:parentPublicationTitle>Journal of The Royal Society Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50339608188a53812036a4226a48ec56"><gtr:id>50339608188a53812036a4226a48ec56</gtr:id><gtr:otherNames>Elder A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>E7D454C2DA4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F79B8759-269B-48B2-B3D4-8491AB3C0531</gtr:id><gtr:title>Control of Aurora-A stability through interaction with TPX2.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85cda40c6dc030b9191440b59fa0b2e3"><gtr:id>85cda40c6dc030b9191440b59fa0b2e3</gtr:id><gtr:otherNames>Giubettini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>qsYiGozPrqz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B697BE35-644C-4C55-B0B2-586BF1D9F608</gtr:id><gtr:title>The Aurora-A/TPX2 complex: a novel oncogenic holoenzyme?</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/858039ab6a979ab212e7c21d77784b9a"><gtr:id>858039ab6a979ab212e7c21d77784b9a</gtr:id><gtr:otherNames>Asteriti IA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>gdPH6bD6W2x</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1EEB447-61D8-4A20-8EF0-321DF41E6F92</gtr:id><gtr:title>Spatiotemporal organization of Aurora-B by APC/CCdh1 after mitosis coordinates cell spreading through FHOD1.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dff684aa563c661949242d8c548044ce"><gtr:id>dff684aa563c661949242d8c548044ce</gtr:id><gtr:otherNames>Floyd S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>doi_55f985985bf5fe5d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F67D1D40-8A8F-4ADC-9F67-3C321D134DE8</gtr:id><gtr:title>Measuring proteolysis in mitosis.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/320d2d43ada4844b2834d0ecd84e29be"><gtr:id>320d2d43ada4844b2834d0ecd84e29be</gtr:id><gtr:otherNames>Lindon C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>55C741B6209</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53E0172E-9E1E-4DFE-9A31-56C7CE3DCE72</gtr:id><gtr:title>Affinity purification of protein complexes from Drosophila embryos in cell cycle studies.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63be09983312217ba10d7138c2616ba2"><gtr:id>63be09983312217ba10d7138c2616ba2</gtr:id><gtr:otherNames>Lipinszki Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>58ac1c57173052.21087202</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC014F86-451A-46D0-9970-91BC1EB581FA</gtr:id><gtr:title>Early mitotic degradation of Nek2A depends on Cdc20-independent interaction with the APC/C.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2dfffde24a2fd96a65ed16f9897baa06"><gtr:id>2dfffde24a2fd96a65ed16f9897baa06</gtr:id><gtr:otherNames>Hayes MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>D3DCE4C3F99</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1656FF6C-9B74-408E-A1D2-CE76FE33A340</gtr:id><gtr:title>Control of mitotic exit and cytokinesis by the APC/C.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/320d2d43ada4844b2834d0ecd84e29be"><gtr:id>320d2d43ada4844b2834d0ecd84e29be</gtr:id><gtr:otherNames>Lindon C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>D364608A5E9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB1158D0-F81D-49B8-886A-1971059FD769</gtr:id><gtr:title>Spastin couples microtubule severing to membrane traffic in completion of cytokinesis and secretion.</gtr:title><gtr:parentPublicationTitle>Traffic (Copenhagen, Denmark)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6436aaa35899e77d54d06d100581078c"><gtr:id>6436aaa35899e77d54d06d100581078c</gtr:id><gtr:otherNames>Connell JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1398-9219</gtr:issn><gtr:outcomeId>A4E477353FF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36D6C882-9BF2-4CC0-AB4D-19C7CA793FBF</gtr:id><gtr:title>Substrate targeting by the ubiquitin-proteasome system in mitosis.</gtr:title><gtr:parentPublicationTitle>Seminars in cell &amp; developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/816ef8b1b2073b67a9afcf678ca5a97f"><gtr:id>816ef8b1b2073b67a9afcf678ca5a97f</gtr:id><gtr:otherNames>Min M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1084-9521</gtr:issn><gtr:outcomeId>58ac1c576a4725.28607205</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G120/892</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>